Latest News by Industry
Xeris Biopharma Holdings, Inc. [XERS] has reported fiscal Q1 loss of $16.80 million.
On a per-share basis, the DE based company said its diluted earnings are $0.12.
The Pharmaceutical Preparations firm posted revenue of $33.20 million in this period.
Also Read: